NAMS:NASDAQ, NewAmsterdam Pharma Company N.V.

NAMS stock overview

NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ) closed at $18.41 on November 20, 2026, down 5.64% on the day. The stock trades 56.4% below its 52-week high of $42.21 and 2.8% above its 52-week low of $17.90. Over the past year, it lost 53.2%. NewAmsterdam Pharma Company N.V. is part of the Health Care sector.

Key figures

Price
$18.41
Day change
-5.64%
Volume
1,744,982
Average volume
1,644,634
Market cap
2B+
52-week range
$17.90 – $42.21
50-day average
$21.18
200-day average
$28.90

Price action over the past year

In 252 trading sessions since November 20, 2025, NAMS closed higher on 120 days (48%). Its best day was May 7, 2026 (+12.46%) and its worst was September 9, 2026 (-11.08%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

NAMS news

About NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

Similar stocks

Find more stocks like NAMS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.